NCT03141684 2026-06-03Testing Atezolizumab Alone or Atezolizumab Plus Bevacizumab in People With Advanced Alveolar Soft Part SarcomaNational Cancer Institute (NCI)Phase 2 Active not recruiting63 enrolled 1 FDA